What Neurofinity does

Neurofinity is a Sedona, Arizona-based private healthcare technology company founded in 2025 that delivers a technology-enabled, whole-person care model for opioid use disorder (OUD). The company embeds its offering inside existing care delivery organizations — health systems, outpatient clinics, and residential treatment centers — rather than marketing directly to consumers. Its core product is the Treus Recovery Intelligence Platform, an AI-assisted longitudinal recovery management system that combines continuous data integration across clinical, behavioral, and social determinants of health (SDOH) inputs with proprietary measurement frameworks (Psychosocial Vital Signs and Recovery Vital Indicators) and adaptive care plans spanning five recovery stages.

Treus is augmented by two human service layers: Amplified Peer Recovery Professionals (APRPs), who provide lived-experience peer support, and Super Navigators, professionally trained care coordinators who resolve root-cause SDOH barriers (housing, employment, transportation, criminal justice involvement) and ensure continuity across hospital, residential treatment, outpatient, sober living, home, and community recovery settings. Operational deployment is anchored by a flagship partnership with Morse Clinics in North Carolina and a co-development relationship with the University of Virginia health system.

Neurofinity generates revenue primarily through value-based reimbursement arrangements that align financial incentives with measurable recovery outcomes rather than episodic service volume. The company maintains an ecosystem of technology (GenieMD, Videra Health), SDOH (Upside Housing), peer staffing (Promise Resource Network), and policy/government relations (McGuireWoods Consulting, Tripp|Hollander Advisors) partners. The company is privately held, co-founded by Raphael Rakowski (CEO), Paula Calabrese (CPO), and Andy Lipman (CFO), with additional leadership including Rachel Blasko (COO) and Dr. Justin Yang (CMO), and has 1-10 employees.

Name

Neurofinity

Legal name

Neurofinity

Website

https://neurofinity.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Neurofinity is a Sedona-based private healthcare technology company that embeds an AI-assisted OUD recovery platform (Treus) plus peer recovery and care navigation services inside health systems, clinics, and residential treatment centers, with value-based reimbursement tied to recovery outcomes.

Ownership category

akta.pro rank

Product category

Behavioral Health Technology / Addiction Recovery Platform

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

akta.pro secondary industry

Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination) (HLALABAG)

Keywords

• Opioid use disorder recovery
• Behavioral health technology
• Peer recovery support
• Care coordination platform
• Value-based care delivery

Headquarters

HQ city

Sedona

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Value-Based Reimbursement: Neurofinity's primary revenue model is anchored in value-based reimbursement, where carefully measured patient recovery metrics are combined with economic impact data to create a mutually aligned value proposition for patients, providers, and payers. This approach aligns financial incentives with measurable recovery outcomes rather than episodic service volume.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Neurofinity delivers a personalized, technology-enabled end-to-end OUD care model combining the AI-assisted Treus Recovery Intelligence Platform with Amplified Peer Recovery Professionals (APRPs) and Super Navigators. The platform provides longitudinal measurement, adaptive care planning, and coordinated workflows across hospitals, residential treatment centers, clinics, sober living, home, and community recovery settings. Provider partners receive qualified personnel, elevated training/credentialing, and the Treus technology infrastructure to deliver continuous, whole-person recovery support.

Product overview

Neurofinity offers a unified platform-plus-services model for continuous opioid use disorder (OUD) recovery, built around the Treus Recovery Intelligence Platform as its core technology layer. The platform is complemented by two human-centered service offerings: Amplified Peer Recovery Professionals (APRPs), who provide peer-based emotional support and lived-experience connection, and Super Navigators, who coordinate care and resolve social determinants of health barriers. All three components are integrated and mutually reinforcing — the Treus platform supports and amplifies APRPs and Super Navigators, while the human services provide trust, accountability, and real-world context that enrich the platform's data and adaptive capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• Treus™ Recovery Intelligence: AI-assisted Recovery Intelligence Platform purpose-built for opioid use disorder, combining longitudinal measurement, adaptive care planning, and coordinated care workflows to personalize recovery support over time.

Products and services

• Treus Recovery Intelligence Platform An AI-assisted longitudinal recovery management system purpose-built for opioid use disorder, combining real-time measurement, adaptive care planning, and coordinated care workflows to personalize recovery support across all care settings over time. Features include Recovery Vital Indicators, Psychosocial Vital Signs, and an Outcomes Dashboard. Sold to healthcare provider organizations (health systems, clinics, residential treatment centers) as the technology backbone of Neurofinity's embeddable OUD care model.
• Amplified Peer Recovery Professionals (APRPs) Uniquely trained and certified patient partners with lived opioid use disorder experience who provide emotional trust and authentic connection, working alongside patients, Super Navigators, and clinical teams, and supported by the Treus Recovery Intelligence Platform to deliver continuous 24/7 engagement throughout recovery. Delivered to healthcare provider organizations as embedded personnel within their care teams.
• Super Navigators Professionally trained navigators who represent patients across the entire care continuum, collaborate with care providers, resolve root-cause social determinants of health challenges (housing, jobs, transportation, criminal justice), and ensure continuity and cohesion across multiple providers and therapies — supported by the Treus Recovery Intelligence Platform. Delivered to healthcare provider organizations as embedded personnel.

Quantifiable outcome

• Overdose mortality is declining significantly — but the OUD disease burden remains enormous and substantially under-measured, with an annual economic burden of the opioid crisis exceeding $1 trillion.
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

• Morse ClinicsflagshipStrategic or Co-development PartnerMorse Clinics serves as a primary operating and launch partner for Neurofinity in North Carolina, representing the first deployment of the Neurofinity care model in a live clinical environment. This is a flagship partnership for market validation and model refinement.
• University of VirginiacoreStrategic or Co-development PartnerUniversity of Virginia operates as a health system partner, integrating the Neurofinity model within its existing care delivery infrastructure as part of a strategic co-development relationship focused on evidence-based OUD care transformation.
• GenieMDcoreTechnology or IntegrationGenieMD provides OUD care technology platform capabilities as part of Neurofinity's broader technology ecosystem, contributing to the technology infrastructure supporting the Treus platform's care coordination and clinical enablement functions.
• Videra HealthcoreTechnology or IntegrationVidera Health provides AI behavioral health platform technology integrated into Neurofinity's ecosystem, supporting the AI-assisted measurement and monitoring capabilities of the Treus Recovery Intelligence Platform.
• Upside HousingcoreStrategic or Co-development PartnerUpside Housing provides housing support services addressing social determinants of health for Neurofinity patients, integrated into the Super Navigator workflow to resolve housing instability — a key driver of relapse and barrier to recovery.
• Promise Resource NetworkcoreStrategic or Co-development PartnerPromise Resource Network provides peer staffing, training, and oversight services as part of Neurofinity's clinical and peer support ecosystem, contributing to the APRP credentialing and training program and ensuring quality peer recovery support delivery.
• McGuireWoods ConsultingminorImplementation/ SI/ Consulting PartnerMcGuireWoods Consulting provides government relations and advocacy consulting to Neurofinity, supporting policy engagement and regulatory navigation related to OUD care reimbursement, funding, and policy reform.
• Tripp|Hollander AdvisorsminorImplementation/ SI/ Consulting PartnerTripp|Hollander Advisors provides government relations and advocacy consulting services to Neurofinity, supporting efforts to advance supportive policy and reimbursement frameworks for OUD care innovation.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• Videra Health: AI behavioral health platform partner already integrated into Neurofinity's ecosystem. Comparable as an enabling technology provider supporting AI-assisted measurement and monitoring.

Direct peers

• Eleanor Health: Outpatient addiction and mental health provider combining medication-assisted treatment, therapy, and peer recovery support with value-based payer contracts. Comparable integrated OUD/SUD care model with peer-led support.
• Quit Genius (legacy entity): Predecessor identity of Pelago; historically focused on digital addiction treatment. Listed for completeness as a directly overlapping digital SUD/OUD platform.
• Boulder Care: Telehealth-based provider of medication-assisted treatment and peer recovery support for opioid use disorder. Comparable as a digitally delivered, peer-supported OUD care model targeting payer partnerships and outcomes-based contracts.
• Lionrock Recovery: Telehealth provider of substance use disorder treatment including opioid use disorder, delivered via group and individual counseling. Comparable digital OUD/SUD care delivery model.
• Pelago (formerly Quit Genius): Digital substance use disorder treatment platform serving payers, health systems, and employers with virtual care for tobacco, alcohol, and opioid use disorders. Directly comparable as a B2B-embedded digital SUD/OUD platform pursuing value-based contracts.
• Workit Health: Virtual substance use disorder care provider offering medication-assisted treatment and counseling for opioid and alcohol use disorders, with B2B partnerships to health plans and providers. Closely aligned on digital OUD treatment and value-based reimbursement.
• Ophelia: Telehealth platform providing medication-assisted treatment for opioid use disorder, working with health plans and Medicaid on value-based arrangements. Highly comparable on OUD focus, virtual delivery, and payer-aligned reimbursement.

Emerging players

• Charlie Health: Virtual intensive outpatient and mental health platform for adolescents and adults. Adjacent behavioral health virtual care with growing SUD focus; comparable on platform-enabled, longitudinal virtual care delivery.

Broad incumbents

• Lyra Health: Large employer-focused mental health platform expanding into substance use care. Comparable as a broader digital behavioral health incumbent serving enterprises and payers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neurofinity